ACTIVATING PYRUVATE KINASE R

The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).

Saved in:
Bibliographic Details
Main Authors SHELEKHIN, Tatiana, LIN, Jian, LANCIA, David, R. Jr, GREEN, Neal, ERICSSON, Anna, MITCHELL, Lorna, GUSTAFSON, Gary, RICHARD, David, ZHENG, Xiaozhang
Format Patent
LanguageEnglish
French
German
Published 03.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).
Bibliography:Application Number: EP20190862479